131 related articles for article (PubMed ID: 30629571)
1. Establishing Baseline Cervical Cancer Screening Coverage - India, 2015-2016.
Van Dyne EA; Hallowell BD; Saraiya M; Senkomago V; Patel SA; Agrawal S; Ghosh A; Saraf D; Mehrotra R; Dhillon PK
MMWR Morb Mortal Wkly Rep; 2019 Jan; 68(1):14-19. PubMed ID: 30629571
[TBL] [Abstract][Full Text] [Related]
2. Spatial evaluation of prevalence, pattern and predictors of cervical cancer screening in India.
Nilima ; Puranik A; Shreenidhi SM; Rai SN
Public Health; 2020 Jan; 178():124-136. PubMed ID: 31678693
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Cervical Cancer Screening and Awareness among Women in an Urban Community in South India-A Cross Sectional Study.
Reichheld A; Mukherjee PK; Rahman SM; David KV; Pricilla RA
Ann Glob Health; 2020 Mar; 86(1):30. PubMed ID: 32211300
[TBL] [Abstract][Full Text] [Related]
4. [Study on the coverage of cervical and breast cancer screening among women aged 35-69 years and related impact of socioeconomic factors in China, 2013].
Bao HL; Wang LH; Wang LM; Fang LW; Zhang M; Zhao ZP; Cong S
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Feb; 39(2):208-212. PubMed ID: 29495207
[No Abstract] [Full Text] [Related]
5. An epidemiological study of cervical and breast screening in India: district-level analysis.
Monica ; Mishra R
BMC Womens Health; 2020 Oct; 20(1):225. PubMed ID: 33028336
[TBL] [Abstract][Full Text] [Related]
6. Lifetime Prevalence of Cervical Cancer Screening in 55 Low- and Middle-Income Countries.
Lemp JM; De Neve JW; Bussmann H; Chen S; Manne-Goehler J; Theilmann M; Marcus ME; Ebert C; Probst C; Tsabedze-Sibanyoni L; Sturua L; Kibachio JM; Moghaddam SS; Martins JS; Houinato D; Houehanou C; Gurung MS; Gathecha G; Farzadfar F; Dryden-Peterson S; Davies JI; Atun R; Vollmer S; Bärnighausen T; Geldsetzer P
JAMA; 2020 Oct; 324(15):1532-1542. PubMed ID: 33079153
[TBL] [Abstract][Full Text] [Related]
7. Assessing Cervical Cancer Screening Coverage Using a Population-Based Behavioral Risk Factor Survey--Thailand, 2010.
Joseph R; Manosoontorn S; Petcharoen N; Sangrajrang S; Senkomago V; Saraiya M
J Womens Health (Larchmt); 2015 Dec; 24(12):966-8. PubMed ID: 26653868
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and determinants of breast and cervical cancer screening among women aged between 30 and 49 years in India: Secondary data analysis of National Family Health Survey - 4.
Krishnamoorthy Y; Ganesh K; Sakthivel M
Indian J Cancer; 2022; 59(1):54-64. PubMed ID: 33753601
[TBL] [Abstract][Full Text] [Related]
9. Community cancer screening at primary care level in Northern India: determinants and policy implications for cancer prevention.
Sharma P; Khanna D; Pradhan S; Birur P
Fam Med Community Health; 2023 Dec; 11(Suppl 1):. PubMed ID: 38105243
[TBL] [Abstract][Full Text] [Related]
10. Patterns in the prevalence and wealth-based inequality of cervical cancer screening in India.
Muthuramalingam MR; Muraleedharan VR
BMC Womens Health; 2023 Jun; 23(1):337. PubMed ID: 37365552
[TBL] [Abstract][Full Text] [Related]
11. Health care access dimensions and cervical cancer screening in South Africa: analysis of the world health survey.
Akinyemiju TF; McDonald JA; Lantz PM
BMC Public Health; 2015 Apr; 15():382. PubMed ID: 25886513
[TBL] [Abstract][Full Text] [Related]
12. Predictors of cervical cancer screening among Kenyan women: results of a nested case-control study in a nationally representative survey.
Ng'ang'a A; Nyangasi M; Nkonge NG; Gathitu E; Kibachio J; Gichangi P; Wamai RG; Kyobutungi C
BMC Public Health; 2018 Nov; 18(Suppl 3):1221. PubMed ID: 30400916
[TBL] [Abstract][Full Text] [Related]
13. Barriers to cervical cancer screening in women attending the Family Medical Program in Niterói, Rio de Janeiro.
Augusto EF; Rosa ML; Cavalcanti SM; Oliveira LH
Arch Gynecol Obstet; 2013 Jan; 287(1):53-8. PubMed ID: 22886356
[TBL] [Abstract][Full Text] [Related]
14. A cost-utility analysis of cervical cancer screening and human papillomavirus vaccination in the Philippines.
Guerrero AM; Genuino AJ; Santillan M; Praditsitthikorn N; Chantarastapornchit V; Teerawattananon Y; Alejandria M; Toral JA
BMC Public Health; 2015 Jul; 15():730. PubMed ID: 26223975
[TBL] [Abstract][Full Text] [Related]
15. Individual-level and community-level determinants of cervical cancer screening among Kenyan women: a multilevel analysis of a Nationwide survey.
Tiruneh FN; Chuang KY; Ntenda PAM; Chuang YC
BMC Womens Health; 2017 Nov; 17(1):109. PubMed ID: 29141612
[TBL] [Abstract][Full Text] [Related]
16. Prevention of Cervix Cancer in India.
Mishra GA; Pimple SA; Shastri SS
Oncology; 2016; 91 Suppl 1():1-7. PubMed ID: 27463969
[TBL] [Abstract][Full Text] [Related]
17. Advancing cervical cancer prevention in India: implementation science priorities.
Krishnan S; Madsen E; Porterfield D; Varghese B
Oncologist; 2013; 18 Suppl():13-25. PubMed ID: 24334478
[TBL] [Abstract][Full Text] [Related]
18. Meeting the cervical cancer screening needs of underserved women: the National Breast and Cervical Cancer Early Detection Program, 2004-2006.
Tangka FK; O'Hara B; Gardner JG; Turner J; Royalty J; Shaw K; Sabatino S; Hall IJ; Coates RJ
Cancer Causes Control; 2010 Jul; 21(7):1081-90. PubMed ID: 20361353
[TBL] [Abstract][Full Text] [Related]
19. Age-specific performance of careHPV versus Papanicolaou and visual inspection of cervix with acetic acid testing in a primary cervical cancer screening.
Labani S; Asthana S
J Epidemiol Community Health; 2016 Jan; 70(1):72-7. PubMed ID: 26248549
[TBL] [Abstract][Full Text] [Related]
20. Cervical Cancer Screening and Incidence by Age: Unmet Needs Near and After the Stopping Age for Screening.
White MC; Shoemaker ML; Benard VB
Am J Prev Med; 2017 Sep; 53(3):392-395. PubMed ID: 28473240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
